Follow the Avacta Group Plc stock price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). Market capitalisation: €328m. The latest transaction was disclosed on 2 September 2024 (Sale). Among the most active insiders: Tony Gardiner. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Avacta Group Plc is a UK-based company focused on developing diagnostic and therapeutic technologies based on proteins. It emphasizes innovation in the healthcare and biotechnology sectors.